NEU 2.81% $18.65 neuren pharmaceuticals limited

Ann: Neuren Corporate Presentation, October 2019, page-76

  1. 2,167 Posts.
    lightbulb Created with Sketch. 571
    So a end market of potentially $28.5 billion

    even of you half half this potential, this would be revenue stream of $1.42 billion p.a in royalties to Neu assuming ROW is structured similar to current deal ie double digit royalties

    With 100m shares on issue here and minimal outgoings/ expenditure at a guess Neu Sh price would be be well in excess of $150-200p/Sh

    happy to be corrected?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.